Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fusar-Poli

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Psychological Medicine|February 19, 2013
Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal interventionP Fusar-Poli, A R Yung, P McGorry, et al.
Current Pharmaceutical Design|January 14, 2012
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairmentsO D Howes, P Fusar-Poli, M Bloomfield, et al.
Annual Review of Clinical Psychology|January 30, 2014
Attenuated psychosis syndrome: ready for DSM-5.1?P Fusar-Poli, W T Carpenter, S W Woods, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 10, 2012
Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosisP Fusar-Poli, M Byrne, S Badger, et al.
Epidemiology and Psychiatric Sciences|June 14, 2022
Clinical outcomes in brief psychotic episodes: a systematic review and meta-analysisU Provenzani, G Salazar de Pablo, M Arribas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 8, 2018
Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined predictionD Oliver, M Kotlicka-Antczak, A Minichino, et al.
Current Pharmaceutical Design|August 20, 2009
Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacologyS Bhattacharyya, J A Crippa, R Martin-Santos, et al.
Journal of Psychiatric Research|October 20, 2009
Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosisP Fusar-Poli, M Byrne, L Valmaggia, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2009
Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosisP Fusar-Poli, A Meneghelli, L Valmaggia, et al.
European Child & Adolescent Psychiatry|May 1, 2015
Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility studyGiulia Spada, S Molteni, C Pistone, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Psychological Medicine|February 19, 2013
Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal interventionP Fusar-Poli, A R Yung, P McGorry, et al.
Current Pharmaceutical Design|January 14, 2012
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairmentsO D Howes, P Fusar-Poli, M Bloomfield, et al.
Annual Review of Clinical Psychology|January 30, 2014
Attenuated psychosis syndrome: ready for DSM-5.1?P Fusar-Poli, W T Carpenter, S W Woods, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 10, 2012
Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosisP Fusar-Poli, M Byrne, S Badger, et al.
Epidemiology and Psychiatric Sciences|June 14, 2022
Clinical outcomes in brief psychotic episodes: a systematic review and meta-analysisU Provenzani, G Salazar de Pablo, M Arribas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 8, 2018
Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined predictionD Oliver, M Kotlicka-Antczak, A Minichino, et al.
Current Pharmaceutical Design|August 20, 2009
Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacologyS Bhattacharyya, J A Crippa, R Martin-Santos, et al.
Journal of Psychiatric Research|October 20, 2009
Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosisP Fusar-Poli, M Byrne, L Valmaggia, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2009
Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosisP Fusar-Poli, A Meneghelli, L Valmaggia, et al.
European Child & Adolescent Psychiatry|May 1, 2015
Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility studyGiulia Spada, S Molteni, C Pistone, et al.
Pageof 7